The protective effects of liguzinediol on congestive heart failure induced by myocardial infarction and its relative mechanism

BACKGROUND: Heart failure (HF) is one of the most common causes of cardiovascular diseases in the world. Currently, the drugs used to treat HF in the clinic may cause serious side effects. Liguzinediol, 2, 5-dimethyl-3, 6-dimethyl-pyrazine, is a compound synthesized after the structural modification...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Qi, Zhang, Dini, Bi, Yunhui, Zhang, Weiwei, Zhang, Yuhan, Meng, Qinghai, Li, Yu, Bian, Huimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296683/
https://www.ncbi.nlm.nih.gov/pubmed/32549908
http://dx.doi.org/10.1186/s13020-020-00345-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296683/
https://www.ncbi.nlm.nih.gov/pubmed/32549908
http://dx.doi.org/10.1186/s13020-020-00345-7

Ejemplares similares